Companies Cue Health
Cue Health CEO salary & total pay, FY2023: $1.4M
Cue Health (HLTHQ) CEO salary, fiscal 2023: Clint Sever was paid a salary of $551,511 and $1,352,114 in total compensation. Free brief. Every figure links to the company’s own filing.
Cue Health no longer files a proxy statement; its last pay data is FY2023.
Clint Sever's complete compensation dossier
A PDF and a CSV sent to your email: Clint Sever's pay in every fiscal year Cue Health reported it, line by line, with Clint Sever's equity grants and Cue Health's disclosed peer group where the company discloses them. Every row is cited to its filing.
See an example →CEO pay, last three years
- $3,787,962FY2022
- $1,352,114FY2023
CEO total pay was $1,352,114 in fiscal 2023 (Clint Sever), down from $3,787,962 in fiscal 2022 (Ayub Khattak, the CEO that year).
FY2023: salary $551,511 · bonus $0 · stock awards $309,787 · option awards $470,638
Executives and directors
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Ayub Khattak | $576,580 | $0 | $0 | $1,277,447 | $0 | $0 | $17,242 | $1,871,269 |
| former Chief Executive Officer 4 | ||||||||
| Clint Sever | 551,511 | 0 | 309,787 | 470,638 | 0 | 0 | 20,178 | 1,352,114 |
| Chief Executive Officer 5 | ||||||||
| Aasim Javed | 407,423 | 0 | 728,000 | 0 | 0 | 0 | 33,781 | 1,169,204 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2023 total | FY2022 total | FY2021 total | Δ FY2022→2023 |
|---|---|---|---|---|
| Ayub Khattak | $1,871,269 | $3,787,962 | — | ↓ −1,916,693 |
| Clint Sever | 1,352,114 | 3,136,735 | — | ↓ −1,784,621 |
| Aasim Javed | 1,169,204 | 1,017,561 | — | ↑ +151,643 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Our compensation policies and philosophies are designed to align compensation with business objectives, while also enabling us to attract, motivate and retain individuals who contribute to our long-term success. The compensation of our named executive officers has consisted of a base salary and cash bonus, retirement, health and welfare benefits, and equity awards.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Compensia, Inc. |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | false |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2023
| Executive | Award | Exercisable | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|---|
| Aasim Javed | RSU | — | 37,500 | — | $6,000 |
| Aasim Javed | RSU | — | 36,252 | — | 5,800 |
| Aasim Javed | RSU | — | 284,375 | — | 45,500 |
| Ayub Khattak | RSU | — | 427,049 | — | 68,328 |
| Ayub Khattak | PSU | — | 1,774,614 | — | 283,938 |
| Ayub Khattak | RSU | — | 235,905 | — | 37,745 |
| Ayub Khattak | Option | 295,900 | — | 0.4 | — |
| Ayub Khattak | Option | 151,595 | — | 2.08 | — |
| Clint Sever | RSU | — | 349,404 | — | 55,905 |
| Clint Sever | PSU | — | 1,560,686 | — | 249,710 |
| Clint Sever | RSU | — | 193,014 | — | 30,882 |
| Clint Sever | RSU | — | 121,012 | — | 19,362 |
| Clint Sever | Option | 295,900 | — | 0.4 | — |
| Clint Sever | Option | 833,333 | — | 0.48 | — |
| Clint Sever | Option | 1,130,797 | — | 0.48 | — |
| Clint Sever | Option | 55,851 | — | 2.08 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Joshua GhaimIndependent · Audit Committee · Compensation Committee (Chair) · Nominating and Corporate Governance Committee | $74,000 | $33,549 | — | — | — | $107,549 |
| Maria MartinezIndependent · Audit Committee · Compensation Committee · Nominating and Corporate Governance Committee (Chair) | 73,000 | 33,549 | — | — | — | 106,549 |
| Carole FaigIndependent · Audit Committee (Chair) | 70,000 | 33,549 | — | — | — | 103,549 |
| Sachin JainIndependent · Audit Committee · Nominating and Corporate Governance Committee | 62,000 | 33,549 | — | — | — | 95,549 |
| Joanne BradfordIndependent · Compensation Committee · Nominating and Corporate Governance Committee | 59,000 | 33,549 | — | — | — | 92,549 |
Board fee structure and ownership guideline
| Annual cash retainer | $50,000 |
|---|---|
| Annual equity retainer | $190,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 12,000 / 10,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2023 |
|---|---|
| Cash retainers and fees | $338,000 |
| Equity awards (grant-date value) | $167,745 |
| All other compensation | $0 |
| Total cost of the board | $505,745 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Cue Health as a peer
Companies that benchmark against HLTHQ
No companies currently name HLTHQ as a compensation peer in their most recent disclosure.
This is the complete answer, not a partial one — the list is never padded.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Cue Health | 2023 | Clint Sever | $551,511 | $309,787 | $470,638 | $0 | $1,352,114 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2024 | 2024-05-14 | — | — | — | — | — |
| 2023 | 2023-06-05 | — | — | — | — | — |
| 2022 | 2022-09-21 | — | — | — | — | — |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2024 | 2024-05-14 | —a |
| 2023 | 2023-06-05 | —b |
| 2022 | 2022-09-21 | —c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2023 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Tarsadia Capital, LLC | Greater-than-10% holder | 2024-08-23 | D | 1,067,674 | $0 | $0 | Common, indirect | Form 4 ↗ |
| Tarsadia Capital, LLC | Greater-than-10% holder | 2024-08-23 | D | 3,230,779 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Tarsadia Capital, LLC | Greater-than-10% holder | 2024-08-23 | D | 10,684,791 | 0 | 1,068 | Common, indirect | Form 4 ↗ |
| Tarsadia Capital, LLC | Greater-than-10% holder | 2024-08-27 | D | 3,319,000 | 0 | 0 | Common, indirect | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (18 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Ayub Khattak. DEF 14A, filed 2024-04-22. Section “Summary Compensation Table” · page 43. As printed: 1,871,269. View filing ↗
- Section 01, Clint Sever. DEF 14A, filed 2024-04-22. Section “Summary Compensation Table” · page 43. As printed: 1,352,114. View filing ↗
- Section 01, Aasim Javed. DEF 14A, filed 2024-04-22. Section “Summary Compensation Table” · page 43. As printed: 1,169,204. View filing ↗
- Section 08, Joshua Ghaim. DEF 14A, filed 2024-04-22. Section “Director Compensation”. As printed: 107,549. View filing ↗
- Section 08, Maria Martinez. DEF 14A, filed 2024-04-22. Section “Director Compensation”. As printed: 106,549. View filing ↗
- Section 08, Carole Faig. DEF 14A, filed 2024-04-22. Section “Director Compensation”. As printed: 103,549. View filing ↗
- Section 08, Sachin Jain. DEF 14A, filed 2024-04-22. Section “Director Compensation”. As printed: 95,549. View filing ↗
- Section 08, Joanne Bradford. DEF 14A, filed 2024-04-22. Section “Director Compensation”. As printed: 92,549. View filing ↗
- Section 02, Tarsadia Capital, LLC 2024-08-23. Form 4, filed 2024-08-27. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Tarsadia Capital, LLC 2024-08-23. Form 4, filed 2024-08-27. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Tarsadia Capital, LLC 2024-08-23. Form 4, filed 2024-08-27. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Tarsadia Capital, LLC 2024-08-27. Form 4, filed 2024-08-27. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-16. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
- Section 06, 2023 vote. Form 8-K, filed 2023-06-07. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
- Section 06, 2022 vote. Form 8-K, filed 2022-09-27. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 338,000 + equity 167,745 + all other 0 = 505,745, summed across the director compensation table rows.
- Cue Health (subject), Section 10b CEO total. DEF 14A, filed 2024-04-22. CEO total compensation as printed in Cue Health's own proxy. As printed: 1,352,114. View filing ↗